Penza State University: Clinical Trials

3 trials sponsored by Penza State University, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting, 1 unknown. 2 Phase 4, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 42Completed 1, Recruiting 1
Not applicable1Unknown 1

Follow Penza State University: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of the Effect of Long-term Lipid-lowering Therapy in STEMI Patients With Coronavirus Infection COVID-19
Atorvastatin 80mg, Atorvastatin-Ezetimibe - STEMI, Covid19
Not applicableUnknownPenza State University452020-11-202023-11-24
Assessment of the Effects of Long-term Lipid-lowering Therapy in Patients With Primary STEMI or NSTEMI
Atorvastatin 80mg - Myocardial Infarction, Acute, Myocardial Strain
Phase 4RecruitingPenza State University3002020-02-122023-11-24
Assessment of the Effects of Atorvastatin Therapy on Myocardial Deformation Characteristics, in Patients With STEMI
Atorvastatin - Myocardial Infarction
Phase 4CompletedPenza State University2002014-10-012020-03-24

Conditions studied

ST Elevation Myocardial Infarction (3)  ·  Myocardial Infarction (2)  ·  Non-ST Elevated Myocardial Infarction (2)  ·  COVID-19 (1)

Interventions

Atorvastatin (3)  ·  Ezetimibe (1)  ·  Hydroxymethylglutaryl-CoA Reductase Inhibitors (1)  ·  liptruzet (1)

Countries

Russia (3)

Top investigators

Valentin E Oleynikov, DM (1)  ·  Valentin Oleynikov (1)  ·  Valentin Oleynikov, prof. (1)

Results publications

PMID 42651065